New 13D15
New 13G67
Stated intents3
The week of 2026-01-12, 15 holders filed a new Schedule 13D and 67 a new Schedule 13G reporting 5% or more of a company, and 3 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-01-16 | AIFU Inc. | Yif Liu | 78.15% | SCHEDULE 13D |
| 2026-01-16 | AIFU Inc. | Yif Liu | 78.15% | SCHEDULE 13D |
| 2026-01-14 | Blue Line Holdings, Inc. | Joseph C. Henn | 50.4% | SCHEDULE 13D |
| 2026-01-13 | XCF Global, Inc. | Soule Randy | 49.6% | SCHEDULE 13D |
| 2026-01-16 | Anfield Energy Inc. | Uranium Energy Corp | 36.8% | SCHEDULE 13D |
| 2026-01-16 | PetVivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 36.1% | SCHEDULE 13D |
| 2026-01-16 | Iron Horse Acquisition II Corp. | Irho Spac Sponsor LLC | 21% | SCHEDULE 13D |
| 2026-01-16 | Atlas Critical Minerals Corporation | Atlas Lithium Corp | 20.5% | SCHEDULE 13D |
| 2026-01-14 | USA Compression Partners LP | Westerman Interests, Inc. | 12.9% | SCHEDULE 13D |
| 2026-01-15 | Aktis Oncology, Inc. | Eli Lilly and Company | 11.9% | SCHEDULE 13D |
| 2026-01-14 | Aktis Oncology, Inc. | VV Manager II LLC | 10.9% | SCHEDULE 13D |
| 2026-01-16 | Syra Health Corp | Johnson Neil Lawrence | 6.2% | SCHEDULE 13D |
| 2026-01-15 | Fidelity D And D Bancorp Inc | Mcdonald Michael J | 6% | SCHEDULE 13D |
| 2026-01-14 | Zenas BioPharma, Inc. | Leon O. Moulder, Jr. | 5.16% | SCHEDULE 13D |
| 2026-01-16 | Dynatrace, Inc. | Pictet Asset Management Sa | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-01-16 | Texxon Holding Ltd | EXCP XH Holding Limited | 72.08% | SCHEDULE 13G |
| 2026-01-12 | Lafayette Digital Acquisition Corp. I | Lafayette Digital Sponsor I, LLC | 25.63% | SCHEDULE 13G |
| 2026-01-12 | Global Payments Inc | GTCR W Aggregator LP | 15.45% | SCHEDULE 13G |
| 2026-01-16 | Phoenix Education Partners, Inc. | TVG-I-E-AEG Holdings, LP | 13.84% | SCHEDULE 13G |
| 2026-01-15 | G Willi Food International Ltd | Meitav Investment House Ltd | 11.45% | SCHEDULE 13G |
| 2026-01-16 | Quantum Cyber N.V. | Donahue Kevin Michael | 10.7% | SCHEDULE 13G |
| 2026-01-15 | ArrowMark Financial Corp. | ArrowMark Colorado Holdings, LLC | 10.35% | SCHEDULE 13G |
| 2026-01-12 | Freight Technologies, Inc. | Dip Spv I, L.P. | 9.9% | SCHEDULE 13G |
| 2026-01-15 | Century Therapeutics, Inc. | Chen Yu | 9.9% | SCHEDULE 13G |
| 2026-01-16 | Century Therapeutics, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-01-16 | Alpha Compute Corp | Orca Capital AG | 9.9% | SCHEDULE 13G |
| 2026-01-16 | Signing Day Sports, Inc. | Orca Capital AG | 9.9% | SCHEDULE 13G |
| 2026-01-15 | Kayne Anderson BDC, Inc. | State Of Michigan Retirement System | 9.6% | SCHEDULE 13G |
| 2026-01-14 | Outset Medical, Inc. | BML Investment Partners, L.P. | 9.4% | SCHEDULE 13G |
| 2026-01-15 | Viper Energy, Inc. | Kimmeridge Energy Management Company, LLC | 9.1% | SCHEDULE 13G |
| 2026-01-12 | Blue Foundry Bancorp | Glazer Capital, LLC | 8.57% | SCHEDULE 13G |
| 2026-01-13 | Freenome, Inc. | Crcm LP | 8% | SCHEDULE 13G |
| 2026-01-13 | KALA BIO, Inc. | LifeSci Capital LLC | 7.9% | SCHEDULE 13G |
| 2026-01-16 | Adlai Nortye Ltd. | ANL Talent Limited | 7.75% | SCHEDULE 13G |
| 2026-01-16 | Corbus Pharmaceuticals Holdings, Inc. | Aberdeen Group plc | 7.53% | SCHEDULE 13G |
| 2026-01-12 | Damora Therapeutics Inc | Paragon Therapeutics, Inc. | 7.5% | SCHEDULE 13G |
| 2026-01-12 | Damora Therapeutics Inc | Paramora Holding LLC | 7.5% | SCHEDULE 13G |
| 2026-01-14 | Endava plc | Paradice Investment Management LLC | 7.43% | SCHEDULE 13G |
| 2026-01-15 | Century Therapeutics, Inc. | Deep Track Capital, LP | 7.34% | SCHEDULE 13G |
| 2026-01-14 | TGE Value Creative Solutions Corp. | Lineage Point Capital LP | 7.3% | SCHEDULE 13G |
| 2026-01-16 | Buda Juice, Inc. | Grow Funds, LLC. | 7.2% | SCHEDULE 13G |
| 2026-01-16 | Century Therapeutics, Inc. | Venrock Healthcare Capital Partners III, L.P. | 7.1% | SCHEDULE 13G |
| 2026-01-16 | Century Therapeutics, Inc. | Commodore Capital LP | 7.1% | SCHEDULE 13G |
| 2026-01-12 | Art Technology Acquisition Corp | Linden Capital L.P. | 7% | SCHEDULE 13G |
| 2026-01-14 | Bleichroeder Acquisition Corp. II | Continental General Insurance Co | 7% | SCHEDULE 13G |
| 2026-01-13 | Crane Harbor Acquisition Corp. | RichRich Capital LLC | 6.81% | SCHEDULE 13G |
| 2026-01-13 | Freenome, Inc. | One Fin Capital Management LP | 6.8% | SCHEDULE 13G |
| 2026-01-16 | Traws Pharma, Inc. | Chernett Jorey | 6.8% | SCHEDULE 13G |
| 2026-01-14 | Triumph Financial, Inc. | AltraVue Capital, LLC | 6.4% | SCHEDULE 13G |
| 2026-01-15 | Planet Fitness Inc - Cl A | Steadfast Capital Management LP | 6.4% | SCHEDULE 13G |
| 2026-01-16 | Docusign Inc | Jpmorgan Chase & Co. | 6.4% | SCHEDULE 13G |
| 2026-01-16 | Canada Goose Holdings Inc. | Portolan Capital Management, LLC | 6.31% | SCHEDULE 13G |
| 2026-01-13 | Soren Acquisition Corp. | Linden Advisors LP | 6.3% | SCHEDULE 13G |
| 2026-01-13 | Biodesix Inc | Soleus Capital Master Fund, L.P. | 6.3% | SCHEDULE 13G |
| 2026-01-12 | i-80 Gold Corp | Daniel Kaufman | 6.27% | SCHEDULE 13G |
| 2026-01-12 | Innventure, Inc. | Adam Fisher | 6.2% | SCHEDULE 13G |
| 2026-01-14 | Constellation Energy Corp | ECP ControlCo, LLC | 6.1% | SCHEDULE 13G |
| 2026-01-16 | Lafayette Digital Acquisition Corp. I | Linden Capital L.P. | 6.1% | SCHEDULE 13G |
| 2026-01-15 | Wintergreen Acquisition Corp. | Shaolin Capital Management LLC | 5.82% | SCHEDULE 13G |
| 2026-01-16 | Jefferson Capital, Inc. | Burton David M. | 5.8% | SCHEDULE 13G |
| 2026-01-15 | SC II Acquisition Corp. | Shaolin Capital Management LLC | 5.71% | SCHEDULE 13G |
| 2026-01-15 | Quipt Home Medical Corp. | Glazer Capital, LLC | 5.62% | SCHEDULE 13G |
| 2026-01-16 | Range Resources Corp | Boston Partners | 5.57% | SCHEDULE 13G |
| 2026-01-15 | SkyAI, Inc. | Saba Capital Management, L.P. | 5.53% | SCHEDULE 13G |
| 2026-01-15 | Northpointe Bancshares, Inc. | Bay Pond Investors (Bermuda) L.P. | 5.5% | SCHEDULE 13G |
| 2026-01-16 | Grupo Televisa, S.A.B. | Jpmorgan Chase & Co. | 5.5% | SCHEDULE 13G |
| 2026-01-12 | Ardelyx, Inc. | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2026-01-13 | Myriad Genetics Inc | Glenview Capital Management, LLC | 5.3% | SCHEDULE 13G |
| 2026-01-13 | Elme Communities | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2026-01-14 | Erasca, Inc. | Paradigm BioCapital Advisors LP | 5.3% | SCHEDULE 13G |
| 2026-01-16 | Evotec SE | MAK Capital Fund LP | 5.3% | SCHEDULE 13G |
| 2026-01-16 | Newton Golf Company, Inc. | Clifford Jay Thomson | 5.28% | SCHEDULE 13G |
| 2026-01-13 | Bleichroeder Acquisition Corp. II | Linden Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-01-14 | Bleichroeder Acquisition Corp. II | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-01-15 | Oncology Institute, Inc. | Chernett Jorey | 5.2% | SCHEDULE 13G |
| 2026-01-12 | Soundthinking, Inc. | Veradace Partners LP | 5.1% | SCHEDULE 13G |
| 2026-01-16 | DraftKings Inc. | Jpmorgan Chase & Co. | 5.1% | SCHEDULE 13G |
| 2026-01-16 | Open Lending Corporation | Whetstone Capital Advisors, LLC | 5.1% | SCHEDULE 13G |
| 2026-01-16 | Airsculpt Technologies, Inc. | Chernett Jorey | 5.1% | SCHEDULE 13G |
| 2026-01-16 | Valvoline Inc | Boston Partners | 5.09% | SCHEDULE 13G |
| 2026-01-13 | GridAI Technologies Corp. | Strategic EP, LLC | 5% | SCHEDULE 13G |
| 2026-01-16 | Lamb Weston Holdings, Inc. | Jpmorgan Chase & Co. | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-01-16 | Genco Shipping & Trading Ltd | Diana Shipping Inc. intent stated | 14.8% | SCHEDULE 13D/A |
| 2026-01-14 | LEE ENTERPRISES, Inc | Gamco Investors, Inc. Et Al intent stated | 9.2% | SCHEDULE 13D/A |
| 2026-01-15 | OraSure Technologies, Inc. | Altai Capital Management, L.P. intent stated | 5.21% | SCHEDULE 13D/A |
Download this data (CSV)85 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.